Since 2003, Sinapi biomedical has been developing and manufacturing medical devices that have as first priority a clinical or practical improvement compared to competitive products. Sinapi strives to provide devices of excellent quality and reliability, managed by strict and comprehensive quality standards. We focus on providing products with the best cost benefit multiplied by quality benefit. As a team we are motivated by the belief that we are making a long term contribution towards advancing healthcare.


CHEST DRAINAGE: Sinapi developed a compact chest drainage device that enables greater patient mobility while still maintaining all applications of draining chest fluids i.e. after heart -, lung -, trauma surgery, etc. Our mechanical (Scheffler) valve is more efficient than existing systems (water or other dry seal), allowing faster evacuation of blood and air from the chest; shortening chest drainage time, enabling faster removal of the chest catheter and resulting in improved patient outcome.

NUTRITION: Cup feeding supports exclusive breast feeding (expressed breast milk) or exclusive replacement feeding as a safer alternative to bottle feeding. Together with the Department of Neonatology (Groote Schuur Academic Hospital) and specifically Prof David Woods, Sinapi developed a cup in which to safely store, mix and administer feeds.The Department of Nutrition, Western Cape, supported and funded the initial development and today it is used by many hospitals in all provinces of South Africa.

URINARY DRAINAGE: The product specification of the Sinapi Urine Meter was essentially developed by Registered Nurses working in the clinical setting (ICU and HCU) and those in Infection control. The SUM has a 500 ml rigid reservoir, large bag and one-hand-operated taps that were specifically designed to prevent contamination of the operator. Furthermore, the bag is positioned behind the rigid reservoir reducing the height of the device and consequently the chances of the product touching the floor.

OBSTETRICS: Postpartum haemorrhage (PPH) continues to be the leading cause of maternal deaths in developing countries, resulting in an estimated 125,000 deaths per year. Uterine balloon tamponade (UBT) has become increasingly recognised as an effective and safe second-line treatment for intractable PPH and in 2012, the WHO revised their recommendations to include UBT for the management of PPH when uterotonics fail or are unavailable. Read more about Ellavi UBT.